Enerpac Tool Group has had a decent week on price — up 2.1% to $36.08 — but the improvement arrives in the shadow of a sharp earnings-driven selloff in late March, and the Street's valuation expectations sit well above where the stock is trading today.
The most striking datapoint in the current setup is the analyst mean price target of $50.50, implying roughly 40% upside from current levels. That gap is unusually wide. Recent coverage initiations have been tilted constructive: William Blair started at Market Perform in January, while Roth Capital opened a Buy at $48 in September 2025 and CJS Securities entered with Outperform and a $53 target in March 2025. None of the recent actions came from bulge-bracket desks, and the staleness of the target consensus — last formally updated in late March — means the $50.50 figure predates what turned out to be a painful earnings reaction. The practical read: the Street sees a structurally undervalued industrial, but conviction has been modest and targets may drift lower once analysts refresh post-Q2.
The bull case rests on margin improvement and steady organic growth. The most recent quarter showed revenue of $144 million at a 50.7% gross margin, with EBITDA margins around 22.8% and a healthy current ratio above 2.8x. Return on equity runs near 17.7% and net debt is modest at under $50 million against an enterprise value of roughly $2 billion. The bear case is harder to dismiss: revenue slipped 0.7% year-on-year in the latest quarter, adjusted EBITDA margins are compressing, and the macro backdrop — slowing industrial production, elevated tariffs, supply chain headwinds — maps directly to Enerpac's customer base. The EPS surprise factor score of 45 suggests the company has not been a consistent beater relative to estimates, and the YTD price decline of 6.4% reflects that uncertainty.
Short positioning is not the story here. SI % FF has actually edged lower over the week, falling 5.4% to roughly 1.8% of float — light pressure by any standard. Availability in the lending market is ample and borrow costs are minimal at around 0.51% annualised, barely moving even as SI briefly ticked up mid-month before retreating. The ORTEX short score of 31.6 sits in benign territory, and the 52-week utilisation peak of 4.5% underlines how little demand there has been for the borrow at any point in the past year. Options positioning reinforces the same message: the put/call ratio of 0.32 is fractionally below its 20-day average of 0.34 and near the low end of the past year's range. Calls dominate modestly, but the signal is low-conviction rather than aggressively bullish.
One angle worth noting is the institutional holder base. Neuberger Berman added nearly 400,000 shares in the most recent quarter, and Brown Advisory bought over 415,000 — meaningful additions relative to typical turnover in a name this size. Against that, the insider picture is less encouraging. There were no open-market purchases in the trailing 90 days. The net insider figure is technically positive, but that reflects routine share-award activity rather than conviction buying; the CEO and CFO both sold in November at prices comfortably above where the stock trades now.
The next scheduled earnings event is June 23. Given that the March print produced an 8% single-day drawdown — and the five-day follow-through was another 5% lower — the question ahead of that date is whether the industrial demand environment has stabilised enough to narrow the gap between management guidance and what the Street is modelling. How close EPAC gets to the $50 analyst target in the intervening weeks will be a useful tell on whether the institutional buying is building a floor or simply averaging into continued softness.
See the live data behind this article on ORTEX.
Open EPAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
